IRMD announced a cash dividend of 1.05 with an ex-date of Feb. 10, 2023
|Mr. Roger E. Susi||Founder, Chairman, CEO & Pres||615.27k||N/A||1953|
|Mr. Randy Waddell||VP of Worldwide Sales & Marketing||482.73k||N/A||N/A|
|Mr. John F. Glenn||Chief Financial Officer||N/A||N/A||1962|
|Mr. Chris Williamson||Exec. VP of Continuous Improvement & Information Technology||N/A||N/A||N/A|
|Mr. Matt Garner||Controller||N/A||N/A||N/A|
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
IRadimed Corporation’s ISS Governance QualityScore as of February 1, 2023 is 7. The pillar scores are Audit: 8; Board: 10; Shareholder Rights: 4; Compensation: 6.